Amrubicin, also known as SM-5887, is primarily used in cancer research, especially small cell lung cancer (SCLC). It works by intercalating into DNA and inhibiting the activity of topoisomerase II, which disrupts DNA replication and transcription. This ultimately leads to the inhibition of cell growth and induces cell death.
Usually ships within 24 hours.